Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Why brands are running to Strava
Starbucks announced a nationwide partnership with fitness app Strava, asking participants to walk 22 minutes a day for at least 10 days.
Tariffs forced Temu to slash its U.S. ad spend on nearly every platform
The Chinese e-commerce giant traded upper-funnel reach for high-intent shoppers — and still grew its user base.
Why DSW and other brands are pivoting back to ‘old’ marketing tactics
Amid AI and digital saturation, DSW is shifting ad spend to real-life activations and traditional media to deepen customer connections.